Related Experiment Video
Updated: Feb 11, 2026

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells
Published on: September 24, 2020
The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer
Miho Tanaka1,2, Jason H Fine1,2, Christina L Kirkham1,2
1Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Abstract:
Natural killer (NK) cells express receptors specific for MHC class I (MHC-I) molecules involved in "missing-self" recognition of cancer and virus-infected cells. Here we elucidate the role of MHC-I-independent NKR-P1B:Clr-b interactions in the detection of oncogenic transformation by NK cells. Ras oncogene overexpression was found to promote a real-time loss of Clr-b on mouse fibroblasts and leukemia cells, mediated in part via the Raf/MEK/ERK and PI3K pathways. Ras-driven Clr-b downregulation occurred at the level of the Clrb (Clec2d) promoter, nascent Clr-b transcripts, and cell surface Clr-b protein, in turn promoting missing-self recognition via the NKR-P1B inhibitory receptor. Both Ras- and c-Myc-mediated Clr-b loss selectively augmented cytotoxicity of oncogene-transformed leukemia cells by NKR-P1B+ NK cells in vitro and enhanced rejection by WT mice in vivo Interestingly, genetic ablation of either one (Clr-b+/-) or two Clr-b alleles (Clr-b-/-) enhanced survival of Eμ-cMyc transgenic mice in a primary lymphoma model despite preferential rejection of Clr-b-/- hematopoietic cells previously observed following adoptive transfer into naïve wild-type mice in vivo Collectively, these findings suggest that the inhibitory NKR-P1B:Clr-b axis plays a beneficial role in innate detection of oncogenic transformation via NK-cell-mediated cancer immune surveillance, in addition to a pathologic role in the immune escape of primary lymphoma cells in Eμ-cMyc mice in vivo These results provide a model for the human NKR-P1A:LLT1 system in cancer immunosurveillance in patients with lymphoma and suggest it may represent a target for immune checkpoint therapy.Significance: A mouse model shows that an MHC-independent NK-cell recognition axis enables the detection of leukemia cells, with implications for a novel immune checkpoint therapy target in human lymphoma. Cancer Res; 78(13); 3589-603. ©2018 AACR.
Insights
Natural killer cells detect oncogenic transformation via MHC-I-independent NKR-P1B:Clr-b interactions. This pathway enhances leukemia cell rejection, suggesting a novel immune checkpoint therapy target for lymphoma.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Signaling
Background:
- Natural killer (NK) cells typically recognize cancer and virus-infected cells through MHC class I (MHC-I) "missing-self" recognition.
- The NKR-P1B:Clr-b axis represents an alternative, MHC-independent pathway for NK cell recognition.
Purpose of the Study:
- To elucidate the role of the MHC-I-independent NKR-P1B:Clr-b interaction in NK cell detection of oncogenic transformation.
- To investigate the mechanisms and implications of Clr-b downregulation in cancer development and immune surveillance.
Main Methods:
- Investigated Clr-b expression changes in mouse fibroblasts and leukemia cells upon Ras oncogene overexpression.
- Utilized molecular pathways (Raf/MEK/ERK, PI3K) to understand Ras-driven Clr-b downregulation.
- Assessed NK cell cytotoxicity in vitro and tumor rejection in vivo in mouse models with altered Clr-b expression or NKR-P1B activity.
Main Results:
- Ras oncogene overexpression led to rapid Clr-b loss on cancer cells via specific signaling pathways.
- Clr-b downregulation promoted NK cell recognition and rejection of oncogene-transformed leukemia cells.
- Genetic ablation of Clr-b influenced lymphoma progression and NK cell-mediated rejection dynamics.
Conclusions:
- The NKR-P1B:Clr-b axis plays a crucial role in innate immune surveillance against oncogenic transformation.
- This pathway's dual role in immune surveillance and potential immune escape highlights its complexity in cancer.
- The findings suggest the human NKR-P1A:LLT1 system as a potential target for immune checkpoint therapy in lymphoma.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Facilitated Transport
Facilitated Transport
Social Facilitation
Hypothalamic-Pituitary Axis
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...

